Develops biologics for neurodegenerative diseases.
Jun 2026Revenue $8.02M/yrExpenses $31.2M/yr
No trendCash runway ≈ 2.7 years from Jun 2026
Figures by year
When will Coya Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $8.02M and expenses $31.2M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $7.95M | $30.5M | −$22.6M |
| Dec 2024 | $3.55M | $20.8M | −$17.2M |
| Dec 2023 | $6.00M | $13.9M | −$7.90M |
| Dec 2022 | $0.00 | $9.81M | −$9.81M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.